WEBSITE BSE:524136 NSE: PEE CEE COSM Inc. Year: 1986 Industry: Household & Personal Products My Bucket: Add Stock
Last updated: 11:27
No Notes Added Yet
1. Business Overview
Pee Cee Cosma Sope Ltd. is an Indian company primarily engaged in the manufacturing and sale of various household and personal care products. As indicated by its name, its core business likely centers around personal wash products (soaps), but it may also include other segments such as detergents, cosmetics, and other personal hygiene items. The company's business model involves manufacturing these products and distributing them through various channels to reach consumers across different markets, generating revenue from product sales.
2. Key Segments / Revenue Mix
While specific segment breakdowns are not publicly available without detailed financial reports, based on its name and industry, the company's revenue is likely predominantly derived from:
Personal Wash Products: Soaps, body washes, and related personal hygiene items.
Other Household Products: Potentially detergents, surface cleaners, or other non-personal care items.
Cosmetics/Personal Care: May include lotions, creams, hair care, or other beauty products.
The exact percentage contribution from each segment is not disclosed.
3. Industry & Positioning
Pee Cee Cosma Sope Ltd. operates in the highly competitive Indian Household & Personal Products (HPP) industry. This sector is characterized by the presence of large multinational corporations (e.g., HUL, P&G, Dabur, Godrej Consumer Products) with strong brands, extensive distribution networks, and significant marketing budgets, alongside numerous regional and local players. Pee Cee Cosma Sope Ltd. likely positions itself as a regional or niche player, possibly focusing on specific price points, consumer segments, or geographical areas where it can leverage local manufacturing and distribution strengths to compete against larger rivals.
4. Competitive Advantage (Moat)
For a company of its likely size in such a competitive market, Pee Cee Cosma Sope Ltd. may possess limited wide competitive moats comparable to industry leaders. Potential nascent advantages could include:
Regional Brand Equity: A strong local brand recall in specific geographical pockets.
Cost Efficiency: Ability to manufacture and distribute products at a lower cost, allowing for competitive pricing.
Distribution Network: A well-established distribution network in its target regional markets.
However, these are often susceptible to competition and may not be as durable as the brand strength or economies of scale held by larger players.
5. Growth Drivers
Key factors that could drive the company's growth over the next 3-5 years include:
Increasing Disposable Income: Rising incomes in India lead to higher consumption of HPP products.
Urbanization & Premiumization: Growing urban populations and changing lifestyles drive demand for more sophisticated and specialized personal care products.
Distribution Expansion: Expanding its reach into new geographies or strengthening existing distribution channels.
Product Innovation: Introducing new products, variants, or entering new categories to cater to evolving consumer preferences.
Focus on Value Segment: Capitalizing on the large value-conscious consumer base in India.
6. Risks
Intense Competition: The HPP market is highly competitive, with established players and new entrants constantly vying for market share.
Raw Material Price Volatility: Fluctuations in prices of key raw materials (e.g., oils, chemicals, packaging) can impact profitability.
Changing Consumer Preferences: Rapid shifts in consumer tastes, trends, and demand for specific ingredients (e.g., natural, organic) require constant adaptation.
Distribution Challenges: Maintaining and expanding an efficient distribution network across diverse Indian markets can be costly and complex.
Regulatory Environment: Changes in product standards, labeling requirements, or environmental regulations can affect operations.
Brand Loyalty & Marketing Spend: Competing with the significant marketing and advertising spends of larger companies to build and maintain brand loyalty.
7. Management & Ownership
Pee Cee Cosma Sope Ltd., like many Indian companies, is likely to have a promoter (founder family) driven management and ownership structure. The promoters typically hold a significant stake, influencing strategic direction and operational decisions. The quality of management would depend on their ability to navigate the competitive HPP landscape, innovate, expand efficiently, and maintain financial discipline. Specific details on individual management personnel and exact ownership percentages are not available in this overview.
8. Outlook
Pee Cee Cosma Sope Ltd. operates in an attractive market supported by India's large and growing consumer base, increasing disposable incomes, and evolving consumption patterns. This offers significant headroom for growth, particularly for players that can effectively cater to regional demands or specific value segments. However, the company faces substantial challenges from entrenched domestic and multinational players with superior resources, brand power, and scale. Its ability to carve out sustainable market share will depend on strategic product innovation, efficient cost management, strengthening its distribution network, and building a distinct brand identity amidst fierce competition. Without strong competitive moats, sustained profitability and growth will require consistent execution and agility in responding to market dynamics.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹88 Cr.
Stock P/E 9.2
P/B 1.6
Current Price ₹333
Book Value ₹ 211.9
Face Value 10
52W High ₹580
Dividend Yield 0.9%
52W Low ₹ 285.6
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 23 | 22 | 23 | 25 | 33 | 29 | 33 | 30 | 37 | 33 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 23 | 22 | 23 | 26 | 33 | 29 | 33 | 30 | 37 | 33 |
| Total Expenditure | 22 | 21 | 22 | 25 | 33 | 28 | 32 | 27 | 33 | 29 |
| Operating Profit | 1 | 1 | 0 | 0 | 1 | 1 | 2 | 3 | 4 | 4 |
| Interest | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 3 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Profit After Tax | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 3 |
| Adjustments | -0 | -0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 3 |
| Adjusted Earnings Per Share | 3 | 2.6 | 0.4 | 0.4 | 0.5 | 0.6 | 2.9 | 5.5 | 9.2 | 9.5 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 81 | 75 | 71 | 76 | 76 | 74 | 82 | 93 | 125 | 134 | 141 | 133 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 0 |
| Total Income | 81 | 75 | 71 | 76 | 76 | 74 | 83 | 93 | 125 | 134 | 142 | 133 |
| Total Expenditure | 77 | 70 | 68 | 70 | 71 | 70 | 76 | 90 | 119 | 118 | 128 | 121 |
| Operating Profit | 4 | 5 | 4 | 6 | 5 | 4 | 7 | 3 | 6 | 16 | 15 | 13 |
| Interest | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 2 | 3 | 2 | 6 | 4 | 3 | 6 | 2 | 3 | 14 | 13 | 9 |
| Provision for Tax | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 4 | 3 | 2 |
| Profit After Tax | 1 | 2 | 2 | 4 | 3 | 2 | 5 | 2 | 2 | 10 | 10 | 7 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 1 | 2 | 2 | 4 | 3 | 2 | 5 | 2 | 2 | 10 | 10 | 7 |
| Adjusted Earnings Per Share | 5.1 | 7.7 | 5.8 | 13.9 | 10.7 | 8 | 18 | 6.4 | 9.4 | 39.5 | 36.3 | 27.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 5% | 15% | 14% | 6% |
| Operating Profit CAGR | -6% | 71% | 30% | 14% |
| PAT CAGR | 0% | 71% | 38% | 26% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -50% | 43% | 22% | 17% |
| ROE Average | 22% | 20% | 17% | 14% |
| ROCE Average | 29% | 25% | 21% | 18% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 15 | 16 | 18 | 20 | 22 | 22 | 27 | 28 | 30 | 40 | 49 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 5 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| Total Current Liabilities | 12 | 10 | 7 | 6 | 7 | 9 | 8 | 12 | 10 | 7 | 8 |
| Total Liabilities | 28 | 26 | 25 | 26 | 29 | 32 | 36 | 47 | 46 | 48 | 57 |
| Fixed Assets | 8 | 7 | 7 | 7 | 6 | 7 | 6 | 14 | 15 | 15 | 15 |
| Other Non-Current Assets | 5 | 5 | 8 | 8 | 8 | 8 | 17 | 18 | 15 | 14 | 15 |
| Total Current Assets | 15 | 14 | 10 | 12 | 15 | 16 | 13 | 15 | 17 | 19 | 28 |
| Total Assets | 28 | 26 | 25 | 26 | 29 | 32 | 36 | 47 | 46 | 48 | 57 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0 |
| Cash Flow from Operating Activities | 5 | 1 | 3 | 2 | 1 | 3 | 0 | 9 | 3 | 6 | 7 |
| Cash Flow from Investing Activities | -1 | -0 | -0 | -0 | -0 | -1 | -0 | -11 | -1 | -1 | -6 |
| Cash Flow from Financing Activities | -4 | -1 | -3 | -2 | -1 | -1 | -2 | 3 | -4 | -5 | -1 |
| Net Cash Inflow / Outflow | 0 | -0 | -0 | -0 | 0 | 2 | -2 | 1 | -1 | -0 | -0 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 0 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 5.09 | 7.74 | 5.82 | 13.86 | 10.72 | 7.96 | 18.01 | 6.37 | 9.4 | 39.47 | 36.31 |
| CEPS(Rs) | 8.75 | 10.83 | 8.58 | 16.42 | 12.94 | 10.78 | 20.23 | 8.86 | 15.1 | 45.52 | 42.48 |
| DPS(Rs) | 1.5 | 1.8 | 2.5 | 3 | 3 | 3 | 3 | 1 | 2 | 5 | 3 |
| Book NAV/Share(Rs) | 54.87 | 60.45 | 66.35 | 77.2 | 84.31 | 84.99 | 103 | 106.37 | 114.77 | 152.23 | 183.54 |
| Core EBITDA Margin(%) | 4.12 | 5.55 | 4.34 | 8.22 | 6.14 | 4.72 | 8.12 | 3.02 | 4.16 | 11.49 | 9.26 |
| EBIT Margin(%) | 3.14 | 4.67 | 3.5 | 7.38 | 5.53 | 4.14 | 8.12 | 2.97 | 3.38 | 10.74 | 9.34 |
| Pre Tax Margin(%) | 2.25 | 3.76 | 2.87 | 7.09 | 5.32 | 3.89 | 7.83 | 2.47 | 2.68 | 10.52 | 9.18 |
| PAT Margin (%) | 1.48 | 2.43 | 1.92 | 4.67 | 3.73 | 2.85 | 5.79 | 1.82 | 2 | 7.81 | 6.83 |
| Cash Profit Margin (%) | 2.55 | 3.4 | 2.83 | 5.54 | 4.5 | 3.86 | 6.51 | 2.53 | 3.21 | 9.01 | 8 |
| ROA(%) | 4.86 | 7.56 | 5.98 | 14.23 | 10.22 | 6.93 | 14.19 | 4.09 | 5.33 | 22.18 | 18.26 |
| ROE(%) | 9.53 | 13.43 | 9.17 | 19.31 | 13.27 | 9.4 | 19.16 | 6.08 | 8.5 | 29.56 | 21.63 |
| ROCE(%) | 12.56 | 17.81 | 12.91 | 25.93 | 17.28 | 11.59 | 23.07 | 7.62 | 10.25 | 35.14 | 28.85 |
| Receivable days | 1.6 | 1.75 | 1.54 | 1.74 | 2.17 | 1.75 | 1.57 | 1.81 | 1.71 | 1.43 | 1.27 |
| Inventory Days | 42.66 | 44.99 | 43.81 | 47.9 | 54.86 | 51.86 | 45.93 | 45.96 | 39.58 | 39.38 | 40.36 |
| Payable days | 12.05 | 13.35 | 8.3 | 8.2 | 9.15 | 9.91 | 11.57 | 10.63 | 6.07 | 8.37 | 12.63 |
| PER(x) | 7.33 | 9.81 | 13.15 | 11.17 | 9.14 | 5.6 | 6.19 | 19.31 | 10.53 | 9.93 | 14.65 |
| Price/Book(x) | 0.68 | 1.26 | 1.15 | 2.01 | 1.16 | 0.52 | 1.08 | 1.16 | 0.86 | 2.57 | 2.9 |
| Dividend Yield(%) | 4.02 | 2.37 | 3.27 | 1.94 | 3.06 | 6.73 | 2.69 | 0.81 | 2.02 | 1.28 | 0.56 |
| EV/Net Sales(x) | 0.21 | 0.35 | 0.34 | 0.57 | 0.38 | 0.19 | 0.4 | 0.48 | 0.29 | 0.78 | 1.01 |
| EV/Core EBITDA(x) | 4.46 | 5.44 | 6.74 | 6.72 | 6.01 | 3.74 | 4.49 | 13.03 | 6.29 | 6.54 | 9.6 |
| Net Sales Growth(%) | 6.43 | -7.44 | -4.77 | 7.63 | -0.49 | -2.76 | 11.24 | 12.69 | 34.33 | 7.33 | 5.2 |
| EBIT Growth(%) | -14.32 | 37.87 | -28.43 | 106.17 | -27.4 | -27.25 | 118.19 | -58.79 | 52.85 | 241.09 | -8.57 |
| PAT Growth(%) | -28.26 | 52.24 | -24.89 | 138.33 | -22.68 | -25.78 | 126.39 | -64.64 | 47.52 | 320.07 | -7.99 |
| EPS Growth(%) | -13.07 | 52.24 | -24.89 | 138.33 | -22.68 | -25.78 | 126.39 | -64.64 | 47.52 | 320.07 | -7.99 |
| Debt/Equity(x) | 0.52 | 0.38 | 0.23 | 0.13 | 0.14 | 0.21 | 0.12 | 0.48 | 0.33 | 0.02 | 0.02 |
| Current Ratio(x) | 1.23 | 1.36 | 1.42 | 2.02 | 2.22 | 1.86 | 1.53 | 1.2 | 1.59 | 2.72 | 3.29 |
| Quick Ratio(x) | 0.32 | 0.39 | 0.13 | 0.16 | 0.48 | 0.81 | 0.15 | 0.23 | 0.15 | 0.78 | 1.24 |
| Interest Cover(x) | 3.53 | 5.16 | 5.58 | 25.18 | 26.31 | 16.28 | 28 | 5.9 | 4.81 | 47.9 | 60.07 |
| Total Debt/Mcap(x) | 0.77 | 0.3 | 0.2 | 0.07 | 0.12 | 0.41 | 0.11 | 0.41 | 0.39 | 0.01 | 0.01 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.17 | 73.08 | 73.08 | 72.57 | 72.58 | 72.58 | 72.58 | 72.58 | 72.58 | 72.58 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 |
| Public | 25.83 | 26.92 | 26.92 | 27.43 | 27.42 | 26.64 | 26.64 | 26.64 | 26.64 | 26.65 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.2 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.